Viewing Study NCT05526066


Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2026-02-27 @ 1:09 AM
Study NCT ID: NCT05526066
Status: TERMINATED
Last Update Posted: 2025-09-26
First Post: 2022-08-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810
Sponsor: Arcturus Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ornithine Transcarbamylase Deficiency View
None OTC Deficiency View
None OTCD View
Keywords:

Keywords

Keyword Brief Keyword Text View
None OTC View
None OTCD View
None Ornithine View
None Transcarbamylase View
None mRNA View
None Ornithine Transcarbamylase Deficiency View
None OTC Deficiency View